CorMedix (CRMD) Q1 2025 Earnings

CRMD·Reported May 6, 2025·Before market open

CorMedix reported Q1 2025 revenue of $39.1M, beat analyst consensus of $29.9M by $9.2M. Diluted EPS came in at $0.30, beat the $0.25 consensus by $0.05.

Revenue

$39.1Mbeat by $9.2M

Consensus: $29.9M

Diluted EPS

$0.30beat by $0.05

Consensus: $0.25

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001213900-25-039908

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q1 2025 Earnings FAQ

Common questions about CorMedix's Q1 2025 earnings report.

CorMedix (CRMD) reported Q1 2025 earnings on May 6, 2025 before market open.

CorMedix reported revenue of $39.1M and diluted EPS of $0.30 for Q1 2025.

Revenue beat the consensus estimate of $29.9M by $9.2M. EPS beat the consensus estimate of $0.25 by $0.05.

You can read the 10-Q periodic report (0001213900-25-039908) directly on SEC EDGAR. The filing index links above go to sec.gov.